Impact on the Length of Stay in Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: .

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-06

Study Completion Date

2019-04-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this prospective observational study among sickle cell children aged 7 to 17 years, who face many experience of pain, pain will be assessed during incentive spirometry sessions. Then a relation between, inspiratory volume, pain and the length of hospital stay will be identified .

Currently, there is no scientific data regarding the correlation between acute pain during vaso-occlusive crisis, incentive spirometry and the impact on length of hospital stay. In fact, physiotherapist experience's in the pediatric department suggests that the pain expressed by the child is not always correlated with inspiratory capacity.

The absence of pain is one of the reasons for hospital discharge after decompensation in patients with sickle cell disease. However, no scientific study has linked incentive spirometry, pain and length of hospital stay.

Investigator assume that these children underestimate the real pain and its impact on breathing pattern, and presume that the maximal inspiratory volume during spirometry sessions will be a better reflect of pain than standard pain scale.

The aim of this study is to show that inspiratory volume would be a better indicator of discharge from hospitalization than actual pain scales.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Response to CFTR Modulators in CF Patients Under 18 Years

NCT04301856

Cystic Fibrosis in Children

RECRUITING

Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis

NCT01706445

Cystic Fibrosis

COMPLETED NA

Respiratory Muscle Training in CF Patients

NCT03190031

Cystic Fibrosis Respiratory Muscles

COMPLETED NA

sPLA2 in EBC During Acute Chest Syndrome

NCT03250585

Sickle Cell Disease Acute Chest Syndrome

COMPLETED

Cystic Fibrosis (CF) Flow Rates Study

NCT00779077

Cystic Fibrosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sickle Cell Disease Pediatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sickle cell children aged 7 to 17 admitted to the pediatric ward
* Children receiving respiratory physiotherapy sessions under medical prescription
* Children hospitalized for more than 24 hours at the CHRO and benefiting from more than one physiotherapy session.
* Absence of opposition of one of the parents to the participation of their child in the study
* Absence of opposition of children able to understand the study

* Sickle cell children under the age of 7 or over 17
* Children with mental deficits
* Non-French-speaking parents
* Children receiving only one physiotherapy session and being hospitalized within 24 hours

Minimum Eligible Age

7 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No